BioRestorative Therapies, Inc. (BRTX) announced Tuesday that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $2 million of its outstanding common stock through June 16, 2026.
"This share repurchase program reflects our confidence in the strength of our clinical development pipeline and the future outlook of our business, said Lance Alstodt, Chief Executive Officer.
The company said the repurchases may be made from time to time in the open market, through privately negotiated transactions, or by other means in accordance with applicable securities laws.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.